Files in This Item:
No electronic version is available yet.
Contact WHO IRIS
Title: Regulatory matters
Issue Date: 1998
Subject: Serotonin Uptake Inhibitors
Fluoxetine
Paroxetine
Sertraline
Piperazines
HIV Protease Inhibitors
Cisapride
Benzimidazoles
Isotretinoin
Anti-Obesity Agents
Antibodies, Monoclonal
Antineoplastic Agents
Ritonavir
N-Methyl-3,4-methylenedioxyamphetamine
Influenza Vaccines
Ritodrine
Flutamide
Nicergoline
Histamine H2 Antagonists
Cyclooxygenase Inhibitors
Vaccines, Attenuated
Misoprostol
Analgesics
Leukotriene Antagonists
Flunitrazepam
Nicergoline
Catechol O-Methyltransferase
Drugs, Chinese Herbal
Legislation, Drug
Fraud
Drug Interactions
Drug Approval
Drug Evaluation
World Health Organization
Australia
Brazil
European Union
Germany
Japan
Sweden
Switzerland
United Kingdom
United States
Context: adverse effects
adverse effects supply and distribution
contraindications adverse effects
administration and dosage supply and distribution
supply and distribution
therapeutic use supply and distribution
contraindications
metabolism
standards
adverse reactions
standards supply and distribution
chemistry
pharmacology
antagonists and inhibitors pharmacology
prevention and control
metadata.dc.subject.other: Pharmaceuticals and Biologicals
URI: http://www.who.int/iris/handle/10665/56067
Appears in Collections:Journal Articles



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.